Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure

Background The prognosis of high or markedly low diastolic blood pressure (DBP) with normalized on‐treatment systolic blood pressure on major adverse cardiovascular events (MACEs) is uncertain. This study examined whether treated isolated diastolic hypertension (IDH) and treated isolated low DBP (IL...

Full description

Bibliographic Details
Main Authors: Wei‐Lun Chang, Ying‐Fan Chen, Yu‐Hsuan Lee, Ming‐Neng Shiu, Po‐Yin Chang, Chao‐Yu Guo, Chi‐Jung Huang, Chern‐En Chiang, Chen‐Huan Chen, Shao‐Yuan Chuang, Hao‐Min Cheng
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032771
_version_ 1797205528177278976
author Wei‐Lun Chang
Ying‐Fan Chen
Yu‐Hsuan Lee
Ming‐Neng Shiu
Po‐Yin Chang
Chao‐Yu Guo
Chi‐Jung Huang
Chern‐En Chiang
Chen‐Huan Chen
Shao‐Yuan Chuang
Hao‐Min Cheng
author_facet Wei‐Lun Chang
Ying‐Fan Chen
Yu‐Hsuan Lee
Ming‐Neng Shiu
Po‐Yin Chang
Chao‐Yu Guo
Chi‐Jung Huang
Chern‐En Chiang
Chen‐Huan Chen
Shao‐Yuan Chuang
Hao‐Min Cheng
author_sort Wei‐Lun Chang
collection DOAJ
description Background The prognosis of high or markedly low diastolic blood pressure (DBP) with normalized on‐treatment systolic blood pressure on major adverse cardiovascular events (MACEs) is uncertain. This study examined whether treated isolated diastolic hypertension (IDH) and treated isolated low DBP (ILDBP) were associated with MACEs in patients with hypertension. Methods and Results A total of 7582 patients with on‐treatment systolic blood pressure <130 mm Hg from SPRINT (Systolic Blood Pressure Intervention Trial) were categorized on the basis of average DBP: <60 mm Hg (n=1031; treated ILDBP), 60 to 79 mm Hg (n=5432), ≥80 mm Hg (n=1119; treated IDH). MACE risk was estimated using Cox proportional‐hazards models. Among the SPRINT participants, median age was 67.0 years and 64.9% were men. Over a median follow‐up of 3.4 years, 512 patients developed a MACE. The incidence of MACEs was 3.9 cases per 100 person‐years for treated ILDBP, 1.9 cases for DBP 60 to 79 mm Hg, and 1.8 cases for treated IDH. Comparing with DBP 60 to 79 mm Hg, treated ILDBP was associated with an 1.32‐fold MACE risk (hazard ratio [HR], 1.32, 95% CI, 1.05–1.66), whereas treated IDH was not (HR, 1.18 [95% CI, 0.87–1.59]). There was no effect modification by age, sex, atherosclerotic cardiovascular disease risk, or cardiovascular disease history (all P values for interaction >0.05). Conclusions In this secondary analysis of SPRINT, among treated patients with normalized systolic blood pressure, excessively low DBP was associated with an increased MACE risk, while treated IDH was not. Further research is required for treated ILDBP management.
first_indexed 2024-04-24T08:52:33Z
format Article
id doaj.art-bdeed504054e4483bfb1edbbde7fe523
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-24T08:52:33Z
publishDate 2024-04-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-bdeed504054e4483bfb1edbbde7fe5232024-04-16T09:33:09ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-04-0113810.1161/JAHA.123.032771Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood PressureWei‐Lun Chang0Ying‐Fan Chen1Yu‐Hsuan Lee2Ming‐Neng Shiu3Po‐Yin Chang4Chao‐Yu Guo5Chi‐Jung Huang6Chern‐En Chiang7Chen‐Huan Chen8Shao‐Yuan Chuang9Hao‐Min Cheng10Division of Faculty Development Taipei Veterans General Hospital Taipei TaiwanDepartment of Internal Medicine Taipei Veterans General Hospital Taipei TaiwanDivision of Faculty Development Taipei Veterans General Hospital Taipei TaiwanDepartment of Pharmacy, College of Pharmaceutical Sciences National Yang Ming Chiao Tung University Taipei TaiwanOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration Silver Spring MD USADivision of Biostatistics and Data science Institute of Public Health, College of Medicine, National Yang Ming Chiao Tung University Taipei TaiwanCenter for Evidence‐based Medicine Taipei Veterans General Hospital Taipei TaiwanSchool of Medicine, College of Medicine National Yang Ming Chiao Tung University Taipei TaiwanSchool of Medicine, College of Medicine National Yang Ming Chiao Tung University Taipei TaiwanInstitute of Population Health Science, National Health Research Institutes Miaoli County TaiwanDivision of Faculty Development Taipei Veterans General Hospital Taipei TaiwanBackground The prognosis of high or markedly low diastolic blood pressure (DBP) with normalized on‐treatment systolic blood pressure on major adverse cardiovascular events (MACEs) is uncertain. This study examined whether treated isolated diastolic hypertension (IDH) and treated isolated low DBP (ILDBP) were associated with MACEs in patients with hypertension. Methods and Results A total of 7582 patients with on‐treatment systolic blood pressure <130 mm Hg from SPRINT (Systolic Blood Pressure Intervention Trial) were categorized on the basis of average DBP: <60 mm Hg (n=1031; treated ILDBP), 60 to 79 mm Hg (n=5432), ≥80 mm Hg (n=1119; treated IDH). MACE risk was estimated using Cox proportional‐hazards models. Among the SPRINT participants, median age was 67.0 years and 64.9% were men. Over a median follow‐up of 3.4 years, 512 patients developed a MACE. The incidence of MACEs was 3.9 cases per 100 person‐years for treated ILDBP, 1.9 cases for DBP 60 to 79 mm Hg, and 1.8 cases for treated IDH. Comparing with DBP 60 to 79 mm Hg, treated ILDBP was associated with an 1.32‐fold MACE risk (hazard ratio [HR], 1.32, 95% CI, 1.05–1.66), whereas treated IDH was not (HR, 1.18 [95% CI, 0.87–1.59]). There was no effect modification by age, sex, atherosclerotic cardiovascular disease risk, or cardiovascular disease history (all P values for interaction >0.05). Conclusions In this secondary analysis of SPRINT, among treated patients with normalized systolic blood pressure, excessively low DBP was associated with an increased MACE risk, while treated IDH was not. Further research is required for treated ILDBP management.https://www.ahajournals.org/doi/10.1161/JAHA.123.032771major adverse cardiovascular eventstreated isolated diastolic hypertensiontreated isolated low diastolic blood pressure
spellingShingle Wei‐Lun Chang
Ying‐Fan Chen
Yu‐Hsuan Lee
Ming‐Neng Shiu
Po‐Yin Chang
Chao‐Yu Guo
Chi‐Jung Huang
Chern‐En Chiang
Chen‐Huan Chen
Shao‐Yuan Chuang
Hao‐Min Cheng
Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
major adverse cardiovascular events
treated isolated diastolic hypertension
treated isolated low diastolic blood pressure
title Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure
title_full Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure
title_fullStr Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure
title_full_unstemmed Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure
title_short Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure
title_sort cardiovascular risk in patients with treated isolated diastolic hypertension and isolated low diastolic blood pressure
topic major adverse cardiovascular events
treated isolated diastolic hypertension
treated isolated low diastolic blood pressure
url https://www.ahajournals.org/doi/10.1161/JAHA.123.032771
work_keys_str_mv AT weilunchang cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT yingfanchen cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT yuhsuanlee cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT mingnengshiu cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT poyinchang cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT chaoyuguo cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT chijunghuang cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT chernenchiang cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT chenhuanchen cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT shaoyuanchuang cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure
AT haomincheng cardiovascularriskinpatientswithtreatedisolateddiastolichypertensionandisolatedlowdiastolicbloodpressure